Polaris Genomics
Other Pharmaceuticals and Biotechnology
Polaris Genomics valuation and funding history | Last updated: November 13, 2020 | 1 funding rounds
Current Valuation
N/A
As of November 13, 2020
Total Funding Raised
N/A
Across 1 round
Last Round
Seed Round
$1.8M
Last Funding
Nov 2020
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| November 13, 2020 | Seed Round | $1.8M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Polaris Genomics is currently valued at N/A as of November 13, 2020.
What is Polaris Genomics Worth in 2026?
Polaris Genomics is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Polaris Genomics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Polaris Genomics Valuation is Determined
Private company valuations like Polaris Genomics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.